These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19302830)

  • 1. Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy.
    Caykoylu A; Ekinci O; Yilmaz E
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):571-2. PubMed ID: 19302830
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
    Chen CK; Wu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1279-80. PubMed ID: 19563854
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1342-3. PubMed ID: 18433967
    [No Abstract]   [Full Text] [Related]  

  • 4. Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient.
    Hung GC; Chen YY
    Pharmacopsychiatry; 2007 Mar; 40(2):83-4. PubMed ID: 17447180
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.
    Hettema JM; Ross DE
    J Clin Psychiatry; 2007 Nov; 68(11):1814-5. PubMed ID: 18052582
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of symptomatic hyperprolactinemia by aripiprazole.
    Wahl R; Ostroff R
    Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
    Shim JC; You YS; Kelly DL
    J Clin Psychopharmacol; 2008 Jun; 28(3):353-4. PubMed ID: 18480699
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
    Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of aripiprazole and tardive dyskinesia.
    Abbasian C; Power P
    J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole treatment of risperidone-induced hyperprolactinemia.
    Chen JX; Su YA; Wang SL; Bian QT; Liu YH; Wang N; Yang FD; Haile C; Kosten TR; Zhang XY
    J Clin Psychiatry; 2009 Jul; 70(7):1058-9. PubMed ID: 19653986
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole treatment for risperidone-associated tic movement: a case report.
    Su JA; Tsang HY; Chou SY; Chung PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):899-900. PubMed ID: 18166258
    [No Abstract]   [Full Text] [Related]  

  • 15. Courses of aripiprazole-associated tardive dyskinesia: report of two cases.
    Wang LJ; Ree SC; Chen CK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):743-4. PubMed ID: 19344742
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvement in Pisa syndrome and tardive dyskinesia following aripiprazole treatment.
    Shan JC; Tseng MC
    J Neuropsychiatry Clin Neurosci; 2009; 21(3):350-1. PubMed ID: 19776324
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement in tardive dyskinesia with aripiprazole use.
    Witschy JK; Winter AS
    Can J Psychiatry; 2005 Mar; 50(3):188. PubMed ID: 15830835
    [No Abstract]   [Full Text] [Related]  

  • 18. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
    Guirguis-Blake J
    Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753
    [No Abstract]   [Full Text] [Related]  

  • 19. Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder.
    Chen MH; Liou YJ
    J Clin Psychopharmacol; 2013 Apr; 33(2):269-70. PubMed ID: 23422384
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.